Kinnate Biopharma Inc.·4

Sep 2, 5:00 PM ET

Williams Richard Thomas 4

4 · Kinnate Biopharma Inc. · Filed Sep 2, 2022

Insider Transaction Report

Form 4
Period: 2022-09-01
Williams Richard Thomas
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-09-01+25,00068,474 total
Footnotes (2)
  • [F1]The Issuer granted RSUs to the Reporting Person. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
  • [F2]Includes 1,141 shares acquired under the Issuer's Employee Stock Purchase Plan in May 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION